tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
CNQX:MDMA
Canadian Market
Holding TSE:MDMA?
Track your performance easily

PharmAla Biotech Holdings, Inc. (MDMA) Financial Statements

58 Followers

PharmAla Biotech Holdings, Inc. Financial Overview

PharmAla Biotech Holdings, Inc.'s market cap is currently ―. The company's EPS TTM is C$-0.007; its P/E ratio is -31.17; PharmAla Biotech Holdings, Inc. is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
May 24Feb 24Nov 23Aug 23May 23
Income Statement-
Total RevenueC$ 139.85KC$ 90.42KC$ 752.47KC$ 438.67K-
Gross ProfitC$ 135.84KC$ 90.42KC$ 459.51KC$ 360.76K-
EBITC$ -413.15KC$ -222.57KC$ 36.48KC$ -80.30KC$ -338.74K
EBITDAC$ -397.37KC$ -206.79KC$ 52.27KC$ -67.07KC$ -325.56K
Net Income Common StockholdersC$ -413.15KC$ -222.57KC$ 36.48KC$ -80.30KC$ -338.74K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 495.81KC$ 40.35KC$ 222.85KC$ 195.04KC$ 495.99K
Total AssetsC$ 2.87MC$ 2.48MC$ 2.39MC$ 2.41MC$ 2.27M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -495.81KC$ -40.35KC$ -222.85KC$ -195.04KC$ -495.99K
Total LiabilitiesC$ 883.60KC$ 1.14MC$ 878.00KC$ 1.03MC$ 812.35K
Stockholders EquityC$ 1.99MC$ 1.34MC$ 1.51MC$ 1.38MC$ 1.46M
Cash Flow-
Free Cash FlowC$ -272.54KC$ -182.50KC$ -42.20KC$ -300.95KC$ -385.92K
Operating Cash FlowC$ -225.10KC$ -106.61KC$ 14.32KC$ -31.52KC$ -313.56K
Investing Cash FlowC$ -47.45KC$ -75.89KC$ -56.51KC$ -269.44KC$ -72.36K
Financing Cash FlowC$ 728.00K-C$ 70.00K-C$ 150.19K
Currency in CAD

PharmAla Biotech Holdings, Inc. Earnings and Revenue History

PharmAla Biotech Holdings, Inc. Debt to Assets

PharmAla Biotech Holdings, Inc. Cash Flow

PharmAla Biotech Holdings, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis